Advertisement
Advertisement

MIST

MIST logo

Milestone Pharmaceuticals Inc. Common Shares

1.27
USD
Sponsored
-0.03
-2.31%
Jun 24, 15:00 UTC -4
Closed
exchange

Pre-Market

1.28

+0.01
+1.10%

Milestone Pharmaceuticals Inc. Common Shares Profile

About

Milestone Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is engaged in developing and commercializing the investigational new drug etripamil for the treatment of cardiovascular indications. The company's lead product candidate consists of MSP-2017, a nasal spray. Milestone Pharmaceuticals Inc. is based in Montr?al, Canada.

Info & Links

CEO

Joseph Oliveto

Headquarters

1111 DR. FREDERIK-PHILIPS BOULEVARD, SUITE 420
MONTREAL, A8 H4M 2X6, CANADA

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.milestonepharma.com

Auditor

PricewaterhouseCoopers LLP

Share holders

21

Employees

38

Milestone Pharmaceuticals Inc. Common Shares Statistics

Valuation Measures

Market Capitalization2

159.86M

Enterprise Value

146.73M

Enterprise Value/EBITDA(ttm)

-2.20

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

5.11

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-656.73%

Return on Invested Capital(ttm)

-110.82%

Return on Assets(ttm)

-81.19%

Income Statement

Revenue(ttm)

238.00K

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

224.00K

EBITDA(ttm)3

-66.68M

Net Income Available to Common(ttm)

-68.36M

Diluted EPS(ttm)

-0.79

Share Statistics

Beta (5Y Monthly)

0.69

52-Week Change

-29.05%

S&P 500 52-Week Change

20.78%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

124.50M

Dividend Yield

0.00%

Float4

94.72M

% Held by Insiders

19.50%

% Held by Institutions

86.18%

Balance Sheet

Total Cash(mrq)

184.22M

Total Cash Per Share(mrq)

1.48

Total Debt(mrq)

58.19M

Total Debt/Equity(mrq)

136.92%

Current Ratio(mrq)

8.01%

Quick Ratio(mrq)

7.96%

Book Value Per Share(mrq)

0.39

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.58

Free Cash Flow(ytd)

-49.34M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement